Updated 2021-03-03
Company | Symbol | TotalGap | FilledGap | UnfilledGap | UnfilledPct |
---|---|---|---|---|---|
Blueprint Medicines Corp | BPMC | 7 | 6 | 1 | 14.3 |
Protagonist Therapeutics Inc | PTGX | 5 | 3 | 2 | 40.0 |
Omeros Corporation | OMER | 7 | 6 | 1 | 14.3 |
Sutro Biopharma Inc | STRO | 6 | 4 | 2 | 33.3 |
Amicus Therapeutics Inc | FOLD | 4 | 4 | 0 | 0.0 |
Halozyme Therapeutics Inc. | HALO | 5 | 3 | 2 | 40.0 |
Esperion Therapeutics Inc. | ESPR | 1 | 1 | 0 | 0.0 |
Grifols SA - ADR - Level III | GRFS | 15 | 15 | 0 | 0.0 |
Collegium Pharmaceutical Inc | COLL | 6 | 6 | 0 | 0.0 |
UroGen Pharma Ltd | URGN | 5 | 5 | 0 | 0.0 |
Hutchison China Meditech Ltd. - ADR | HCM | 2 | 0 | 2 | 100.0 |
Poseida Therapeutics Inc | PSTX | 1 | 1 | 0 | 0.0 |
Applied Molecular Transport Inc | AMTI | 1 | 1 | 0 | 0.0 |
Twist Bioscience Corp | TWST | 15 | 10 | 5 | 33.3 |
Biomarin Pharmaceutical Inc. - Registered Shares | BMRN | 10 | 10 | 0 | 0.0 |
Biocryst Pharmaceuticals Inc. | BCRX | 11 | 6 | 5 | 45.5 |
Invitae Corp | NVTA | 15 | 10 | 5 | 33.3 |
Phibro Animal Health Corp. - Class A | PAHC | 5 | 5 | 0 | 0.0 |
Adaptive Biotechnologies Corp | ADPT | 4 | 4 | 0 | 0.0 |
Nanostring Technologies Inc | NSTG | 8 | 6 | 2 | 25.0 |
Harpoon Therapeutics Inc | HARP | 6 | 4 | 2 | 33.3 |
Adverum Biotechnologies Inc | ADVM | 6 | 5 | 1 | 16.7 |
Ovid Therapeutics Inc | OVID | 3 | 3 | 0 | 0.0 |
Immunogen, Inc. | IMGN | 7 | 5 | 2 | 28.6 |
Zogenix Inc | ZGNX | 8 | 7 | 1 | 12.5 |
Arena Pharmaceuticals Inc | ARNA | 7 | 6 | 1 | 14.3 |
Editas Medicine Inc | EDIT | 7 | 7 | 0 | 0.0 |
Five Prime Therapeutics Inc | FPRX | 5 | 2 | 3 | 60.0 |
Amphastar Pharmaceuticals Inc | AMPH | 8 | 8 | 0 | 0.0 |
Opko Health Inc | OPK | 6 | 6 | 0 | 0.0 |
Pliant Therapeutics Inc | PLRX | 1 | 1 | 0 | 0.0 |
Endo International plc | ENDP | 6 | 5 | 1 | 16.7 |
Travere Therapeutics Inc | TVTX | 2 | 2 | 0 | 0.0 |
VBI Vaccines Inc. | VBIV | 7 | 7 | 0 | 0.0 |
Marinus Pharmaceuticals Inc | MRNS | 6 | 5 | 1 | 16.7 |
Karuna Therapeutics Inc | KRTX | 3 | 2 | 1 | 33.3 |
Arvinas Inc | ARVN | 5 | 4 | 1 | 20.0 |
G1 Therapeutics Inc | GTHX | 9 | 8 | 1 | 11.1 |
Autolus Therapeutics plc - ADR | AUTL | 3 | 3 | 0 | 0.0 |
Flexion Therapeutics Inc | FLXN | 6 | 4 | 2 | 33.3 |
Beam Therapeutics Inc | BEAM | 7 | 4 | 3 | 42.9 |
Aprea Therapeutics Inc | APRE | 1 | 1 | 0 | 0.0 |
Arcus Biosciences Inc | RCUS | 3 | 2 | 1 | 33.3 |
Codexis Inc. | CDXS | 11 | 8 | 3 | 27.3 |
Ardelyx Inc | ARDX | 3 | 2 | 1 | 33.3 |
Intellia Therapeutics Inc | NTLA | 6 | 5 | 1 | 16.7 |
Seagen Inc | SGEN | 8 | 8 | 0 | 0.0 |
Fusion Pharmaceuticals Inc | FUSN | 0 | 0 | 0 | 0.0 |
Acadia Pharmaceuticals Inc | ACAD | 7 | 7 | 0 | 0.0 |
Arcturus Therapeutics Holdings Inc | ARCT | 4 | 2 | 2 | 50.0 |
Verastem Inc | VSTM | 7 | 6 | 1 | 14.3 |
Macrogenics Inc | MGNX | 4 | 2 | 2 | 50.0 |
Kiniksa Pharmaceuticals Ltd - Class A | KNSA | 4 | 3 | 1 | 25.0 |
Akero Therapeutics Inc | AKRO | 3 | 2 | 1 | 33.3 |
Fate Therapeutics Inc | FATE | 10 | 6 | 4 | 40.0 |
Geron Corp. | GERN | 2 | 2 | 0 | 0.0 |
Prothena Corporation plc | PRTA | 5 | 3 | 2 | 40.0 |
Axsome Therapeutics Inc | AXSM | 3 | 2 | 1 | 33.3 |
SIGA Technologies Inc | SIGA | 4 | 3 | 1 | 25.0 |
Emergent Biosolutions Inc | EBS | 16 | 15 | 1 | 6.2 |
Athenex Inc | ATNX | 6 | 6 | 0 | 0.0 |
Revance Therapeutics Inc | RVNC | 7 | 5 | 2 | 28.6 |
Eagle Pharmaceuticals Inc | EGRX | 7 | 7 | 0 | 0.0 |
Larimar Therapeutics Inc | LRMR | 4 | 1 | 3 | 75.0 |
Akouos Inc | AKUS | 0 | 0 | 0 | 0.0 |
Allakos Inc | ALLK | 3 | 2 | 1 | 33.3 |
Allogene Therapeutics Inc | ALLO | 4 | 3 | 1 | 25.0 |
Guardant Health Inc | GH | 6 | 4 | 2 | 33.3 |
Enanta Pharmaceuticals Inc | ENTA | 6 | 5 | 1 | 16.7 |
Kezar Life Sciences Inc | KZR | 2 | 2 | 0 | 0.0 |
Astrazeneca plc - ADR | AZN | 31 | 30 | 1 | 3.2 |
Rhythm Pharmaceuticals Inc. | RYTM | 8 | 7 | 1 | 12.5 |
Revolution Medicines Inc | RVMD | 4 | 4 | 0 | 0.0 |
Nextcure Inc | NXTC | 0 | 0 | 0 | 0.0 |
Regenxbio Inc | RGNX | 9 | 8 | 1 | 11.1 |
Cardiff Oncology Inc | CRDF | 5 | 5 | 0 | 0.0 |
Alector Inc | ALEC | 8 | 5 | 3 | 37.5 |
Calithera Biosciences Inc | CALA | 2 | 2 | 0 | 0.0 |
Stoke Therapeutics Inc | STOK | 8 | 6 | 2 | 25.0 |
AvroBio Inc | AVRO | 5 | 5 | 0 | 0.0 |
Athersys Inc | ATHX | 0 | 0 | 0 | 0.0 |
China Biologic Products Holdings Inc | CBPO | 3 | 2 | 1 | 33.3 |
Dynavax Technologies Corp. | DVAX | 10 | 9 | 1 | 10.0 |
Rubius Therapeutics Inc | RUBY | 6 | 6 | 0 | 0.0 |
Cortexyme Inc | CRTX | 4 | 4 | 0 | 0.0 |
Tricida Inc | TCDA | 6 | 6 | 0 | 0.0 |
Assembly Biosciences Inc | ASMB | 8 | 8 | 0 | 0.0 |
Akebia Therapeutics Inc. | AKBA | 5 | 5 | 0 | 0.0 |
BioNTech SE - ADR | BNTX | 24 | 21 | 3 | 12.5 |
Krystal Biotech Inc | KRYS | 2 | 1 | 1 | 50.0 |
Personalis Inc | PSNL | 4 | 3 | 1 | 25.0 |
TG Therapeutics Inc | TGTX | 9 | 5 | 4 | 44.4 |
Adicet Bio Inc | ACET | 3 | 3 | 0 | 0.0 |
TherapeuticsMD Inc | TXMD | 6 | 5 | 1 | 16.7 |
Biohaven Pharmaceutical Holding Company Ltd | BHVN | 12 | 10 | 2 | 16.7 |
Cymabay Therapeutics Inc | CBAY | 4 | 2 | 2 | 50.0 |
Syndax Pharmaceuticals Inc | SNDX | 3 | 2 | 1 | 33.3 |
Concert Pharmaceuticals Inc | CNCE | 5 | 5 | 0 | 0.0 |
Inovio Pharmaceuticals Inc | INO | 10 | 8 | 2 | 20.0 |
Apellis Pharmaceuticals Inc | APLS | 6 | 5 | 1 | 16.7 |
Compugen Ltd | CGEN | 9 | 8 | 1 | 11.1 |
Spero Therapeutics Inc | SPRO | 8 | 7 | 1 | 12.5 |
Cellectis - ADR | CLLS | 21 | 18 | 3 | 14.3 |
Mersana Therapeutics Inc | MRSN | 3 | 2 | 1 | 33.3 |
Constellation Pharmaceuticals Inc | CNST | 3 | 2 | 1 | 33.3 |
Insmed Inc | INSM | 7 | 6 | 1 | 14.3 |
Alkermes plc | ALKS | 4 | 2 | 2 | 50.0 |
AC Immune SA | ACIU | 5 | 5 | 0 | 0.0 |
Aeglea BioTherapeutics Inc | AGLE | 5 | 4 | 1 | 20.0 |
Epizyme Inc | EPZM | 3 | 3 | 0 | 0.0 |
Catalyst Pharmaceuticals Inc | CPRX | 3 | 3 | 0 | 0.0 |
Supernus Pharmaceuticals Inc | SUPN | 5 | 3 | 2 | 40.0 |
Cara Therapeutics Inc | CARA | 2 | 1 | 1 | 50.0 |
Fulcrum Therapeutics Inc | FULC | 3 | 3 | 0 | 0.0 |
Alx Oncology Holdings Inc | ALXO | 2 | 2 | 0 | 0.0 |
Voyager Therapeutics Inc | VYGR | 3 | 3 | 0 | 0.0 |
Kamada Ltd | KMDA | 19 | 17 | 2 | 10.5 |
FibroGen Inc | FGEN | 7 | 6 | 1 | 14.3 |
Intra-Cellular Therapies Inc | ITCI | 8 | 5 | 3 | 37.5 |
Atara Biotherapeutics Inc | ATRA | 4 | 4 | 0 | 0.0 |
Adaptimmune Therapeutics Plc - ADR | ADAP | 2 | 2 | 0 | 0.0 |
AMGEN Inc. | AMGN | 8 | 8 | 0 | 0.0 |
PDL Biopharma Inc | PDLI | 2 | 2 | 0 | 0.0 |
Orchard Therapeutics plc - ADR | ORTX | 5 | 4 | 1 | 20.0 |
Aurinia Pharmaceuticals Inc | AUPH | 3 | 3 | 0 | 0.0 |
Caredx Inc | CDNA | 7 | 6 | 1 | 14.3 |
Viking Therapeutics Inc | VKTX | 6 | 6 | 0 | 0.0 |
Turning Point Therapeutics Inc | TPTX | 4 | 4 | 0 | 0.0 |
BeiGene Ltd - ADR | BGNE | 12 | 7 | 5 | 41.7 |
Theravance Biopharma Inc | TBPH | 1 | 1 | 0 | 0.0 |
Mirati Therapeutics Inc | MRTX | 5 | 3 | 2 | 40.0 |
Karyopharm Therapeutics Inc | KPTI | 5 | 5 | 0 | 0.0 |
Agenus Inc | AGEN | 0 | 0 | 0 | 0.0 |
Rocket Pharmaceuticals Inc | RCKT | 5 | 4 | 1 | 20.0 |
KalVista Pharmaceuticals Inc | KALV | 6 | 4 | 2 | 33.3 |
Cabaletta Bio Inc | CABA | 2 | 1 | 1 | 50.0 |
Unity Biotechnology Inc | UBX | 8 | 6 | 2 | 25.0 |
Y-Mabs Therapeutics Inc | YMAB | 3 | 2 | 1 | 33.3 |
Nurix Therapeutics Inc | NRIX | 2 | 2 | 0 | 0.0 |
Forma Therapeutics Holdings Inc | FMTX | 0 | 0 | 0 | 0.0 |
IGM Biosciences Inc | IGMS | 5 | 5 | 0 | 0.0 |
uniQure N.V. | QURE | 9 | 9 | 0 | 0.0 |
Galapagos NV - ADR | GLPG | 41 | 40 | 1 | 2.4 |
Wave Life Sciences Ltd. | WVE | 0 | 0 | 0 | 0.0 |
Sanofi - ADR | SNY | 28 | 27 | 1 | 3.6 |
Relay Therapeutics Inc | RLAY | 1 | 1 | 0 | 0.0 |
Illumina Inc | ILMN | 12 | 10 | 2 | 16.7 |
Passage Bio Inc | PASG | 2 | 2 | 0 | 0.0 |
Seres Therapeutics Inc | MCRB | 5 | 4 | 1 | 20.0 |
Celldex Therapeutics Inc. | CLDX | 7 | 5 | 2 | 28.6 |
ChemoCentryx Inc | CCXI | 2 | 2 | 0 | 0.0 |
Ascendis Pharma A/S - ADR | ASND | 3 | 3 | 0 | 0.0 |
Frequency Therapeutics Inc | FREQ | 2 | 2 | 0 | 0.0 |
Osmotica Pharmaceuticals Plc | OSMT | 5 | 5 | 0 | 0.0 |
Novavax, Inc. | NVAX | 15 | 8 | 7 | 46.7 |
Sarepta Therapeutics Inc | SRPT | 7 | 7 | 0 | 0.0 |
Atreca Inc - Class A | BCEL | 3 | 2 | 1 | 33.3 |
Intercept Pharmaceuticals Inc | ICPT | 6 | 6 | 0 | 0.0 |
Aerie Pharmaceuticals Inc | AERI | 1 | 1 | 0 | 0.0 |
Legend Biotech Corp - ADR | LEGN | 2 | 2 | 0 | 0.0 |
Biodelivery Sciences International | BDSI | 6 | 6 | 0 | 0.0 |
Vir Biotechnology Inc | VIR | 7 | 5 | 2 | 28.6 |
Ultragenyx Pharmaceutical Inc. | RARE | 6 | 4 | 2 | 33.3 |
Pacific Biosciences of California Inc | PACB | 13 | 8 | 5 | 38.5 |
Jazz Pharmaceuticals plc | JAZZ | 8 | 6 | 2 | 25.0 |
Ziopharm Oncology, Inc. | ZIOP | 2 | 2 | 0 | 0.0 |
Abbvie Inc | ABBV | 11 | 8 | 3 | 27.3 |
Cue Biopharma Inc | CUE | 5 | 5 | 0 | 0.0 |
Mannkind Corp | MNKD | 4 | 3 | 1 | 25.0 |
Nektar Therapeutics | NKTR | 8 | 7 | 1 | 12.5 |
Anika Therapeutics Inc. | ANIK | 7 | 6 | 1 | 14.3 |
Kala Pharmaceuticals Inc | KALA | 4 | 4 | 0 | 0.0 |
Exelixis Inc | EXEL | 9 | 8 | 1 | 11.1 |
BioXcel Therapeutics Inc | BTAI | 3 | 3 | 0 | 0.0 |
XBiotech Inc | XBIT | 3 | 3 | 0 | 0.0 |
Immunic Inc | IMUX | 13 | 12 | 1 | 7.7 |
Avidity Biosciences Inc | RNA | 3 | 3 | 0 | 0.0 |
GW Pharmaceuticals - ADR | GWPH | 10 | 7 | 3 | 30.0 |
Odonate Therapeutics Inc | ODT | 5 | 3 | 2 | 40.0 |
Castle Biosciences Inc | CSTL | 3 | 3 | 0 | 0.0 |
Gilead Sciences, Inc. | GILD | 5 | 5 | 0 | 0.0 |
Vericel Corp | VCEL | 9 | 3 | 6 | 66.7 |
Vaxart Inc | VXRT | 11 | 9 | 2 | 18.2 |
Immunovant Inc | IMVT | 5 | 5 | 0 | 0.0 |
Zentalis Pharmaceuticals Inc | ZNTL | 1 | 1 | 0 | 0.0 |
Arbutus Biopharma Corp | ABUS | 4 | 2 | 2 | 50.0 |
Relmada Therapeutics Inc | RLMD | 2 | 2 | 0 | 0.0 |
AlloVir Inc | ALVR | 0 | 0 | 0 | 0.0 |
Regeneron Pharmaceuticals, Inc. | REGN | 9 | 9 | 0 | 0.0 |
Ideaya Biosciences Inc | IDYA | 5 | 4 | 1 | 20.0 |
Affimed N.V. | AFMD | 3 | 3 | 0 | 0.0 |
Incyte Corp. | INCY | 9 | 9 | 0 | 0.0 |
Arcutis Biotherapeutics Inc | ARQT | 4 | 1 | 3 | 75.0 |
Argen X SE - ADR | ARGX | 29 | 23 | 6 | 20.7 |
Xenon Pharmaceuticals Inc | XENE | 0 | 0 | 0 | 0.0 |
Neoleukin Therapeutics Inc | NLTX | 4 | 4 | 0 | 0.0 |
Viela Bio Inc | VIE | 3 | 2 | 1 | 33.3 |
Puma Biotechnology Inc | PBYI | 1 | 1 | 0 | 0.0 |
Xeris Pharmaceuticals Inc | XERS | 8 | 8 | 0 | 0.0 |
PTC Therapeutics Inc | PTCT | 2 | 1 | 1 | 50.0 |
Redhill Biopharma - ADR | RDHL | 9 | 7 | 2 | 22.2 |
Myriad Genetics, Inc. | MYGN | 5 | 4 | 1 | 20.0 |
Keros Therapeutics Inc | KROS | 0 | 0 | 0 | 0.0 |
Kodiak Sciences Inc | KOD | 9 | 8 | 1 | 11.1 |
Kaleido Biosciences Inc | KLDO | 4 | 3 | 1 | 25.0 |
Pacira BioSciences Inc | PCRX | 4 | 3 | 1 | 25.0 |
Kura Oncology Inc | KURA | 7 | 5 | 2 | 28.6 |
Deciphera Pharmaceuticals Inc | DCPH | 5 | 5 | 0 | 0.0 |
Sangamo Therapeutics Inc | SGMO | 5 | 5 | 0 | 0.0 |
Acceleron Pharma Inc | XLRN | 6 | 4 | 2 | 33.3 |
Royalty Pharma plc - Class A | RPRX | 3 | 1 | 2 | 66.7 |
Annexon Inc | ANNX | 0 | 0 | 0 | 0.0 |
CRISPR Therapeutics AG | CRSP | 11 | 8 | 3 | 27.3 |
Repare Therapeutics Inc | RPTX | 2 | 1 | 1 | 50.0 |
Inozyme Pharma Inc | INZY | 0 | 0 | 0 | 0.0 |
RAPT Therapeutics Inc | RAPT | 3 | 2 | 1 | 33.3 |
Global Blood Therapeutics Inc. | GBT | 6 | 6 | 0 | 0.0 |
Luminex Corp | LMNX | 9 | 9 | 0 | 0.0 |
Iovance Biotherapeutics Inc | IOVA | 7 | 6 | 1 | 14.3 |
Dicerna Pharmaceuticals Inc | DRNA | 8 | 5 | 3 | 37.5 |
Ngm Biopharmaceuticals Inc | NGM | 3 | 2 | 1 | 33.3 |
Medicinova Inc | MNOV | 8 | 6 | 2 | 25.0 |
Altimmune Inc | ALT | 7 | 5 | 2 | 28.6 |
Ionis Pharmaceuticals Inc | IONS | 11 | 9 | 2 | 18.2 |
Chiasma Inc | CHMA | 3 | 2 | 1 | 33.3 |
I-Mab - ADR | IMAB | 4 | 4 | 0 | 0.0 |
Jounce Therapeutics Inc | JNCE | 3 | 2 | 1 | 33.3 |
Ligand Pharmaceuticals, Inc. - Class B | LGND | 7 | 7 | 0 | 0.0 |
Reata Pharmaceuticals Inc - Class A | RETA | 6 | 6 | 0 | 0.0 |
Avadel Pharmaceuticals plc - ADR | AVDL | 1 | 1 | 0 | 0.0 |
Amarin Corp - ADR | AMRN | 4 | 3 | 1 | 25.0 |
Xencor Inc | XNCR | 7 | 7 | 0 | 0.0 |
Provention Bio Inc | PRVB | 4 | 4 | 0 | 0.0 |
Precision Biosciences Inc | DTIL | 4 | 3 | 1 | 25.0 |
Vaxcyte Inc | PCVX | 2 | 2 | 0 | 0.0 |
Gamida Cell Ltd | GMDA | 9 | 5 | 4 | 44.4 |
MeiraGTx Holdings plc | MGTX | 4 | 4 | 0 | 0.0 |
Cytokinetics Inc | CYTK | 7 | 5 | 2 | 28.6 |
Tcr2 Therapeutics Inc | TCRR | 6 | 3 | 3 | 50.0 |
Moderna Inc | MRNA | 17 | 12 | 5 | 29.4 |
Alexion Pharmaceuticals Inc. | ALXN | 11 | 10 | 1 | 9.1 |
Rigel Pharmaceuticals | RIGL | 6 | 5 | 1 | 16.7 |
Clovis Oncology Inc | CLVS | 0 | 0 | 0 | 0.0 |
Heron Therapeutics Inc | HRTX | 5 | 4 | 1 | 20.0 |
Summit Therapeutics Inc | SMMT | 5 | 2 | 3 | 60.0 |
Sage Therapeutics Inc | SAGE | 8 | 5 | 3 | 37.5 |
Applied Therapeutics Inc | APLT | 2 | 2 | 0 | 0.0 |
Neurocrine Biosciences, Inc. | NBIX | 6 | 6 | 0 | 0.0 |
Bluebird bio Inc | BLUE | 5 | 5 | 0 | 0.0 |
Translate Bio Inc | TBIO | 11 | 10 | 1 | 9.1 |
Albireo Pharma Inc | ALBO | 5 | 2 | 3 | 60.0 |
CytomX Therapeutics Inc | CTMX | 3 | 1 | 2 | 66.7 |
Selecta Biosciences Inc | SELB | 5 | 4 | 1 | 20.0 |
Natera Inc | NTRA | 9 | 5 | 4 | 44.4 |
Denali Therapeutics Inc | DNLI | 7 | 6 | 1 | 14.3 |
VYNE Therapeutics Inc | VYNE | 5 | 4 | 1 | 20.0 |
Eiger BioPharmaceuticals Inc | EIGR | 6 | 5 | 1 | 16.7 |
AnaptysBio Inc | ANAB | 6 | 5 | 1 | 16.7 |
Innoviva Inc | INVA | 5 | 5 | 0 | 0.0 |
Magenta Therapeutics Inc | MGTA | 3 | 3 | 0 | 0.0 |
Paratek Pharmaceuticals Inc. | PRTK | 4 | 2 | 2 | 50.0 |
Exact Sciences Corp. | EXAS | 7 | 4 | 3 | 42.9 |
Generation Bio Co | GBIO | 1 | 0 | 1 | 100.0 |
PetIQ Inc - Class A | PETQ | 9 | 6 | 3 | 33.3 |
Chinook Therapeutics Inc | KDNY | 4 | 3 | 1 | 25.0 |
PRA Health Sciences Inc | PRAH | 10 | 8 | 2 | 20.0 |
Syros Pharmaceuticals Inc. | SYRS | 5 | 5 | 0 | 0.0 |
ORIC Pharmaceuticals Inc | ORIC | 2 | 2 | 0 | 0.0 |
Pandion Therapeutics Inc | PAND | 4 | 3 | 1 | 25.0 |
Coherus Biosciences Inc | CHRS | 3 | 3 | 0 | 0.0 |
NantKwest Inc | NK | 8 | 6 | 2 | 25.0 |
Genmab - ADR | GMAB | 40 | 34 | 6 | 15.0 |
Madrigal Pharmaceuticals Inc | MDGL | 8 | 3 | 5 | 62.5 |
Replimune Group Inc | REPL | 2 | 2 | 0 | 0.0 |
AVITA Medical Inc | RCEL | 28 | 26 | 2 | 7.1 |
Veracyte Inc | VCYT | 9 | 9 | 0 | 0.0 |
Syneos Health Inc - Class A | SYNH | 9 | 7 | 2 | 22.2 |
Crinetics Pharmaceuticals Inc | CRNX | 0 | 0 | 0 | 0.0 |
ANI Pharmaceuticals Inc | ANIP | 8 | 8 | 0 | 0.0 |
Radius Health Inc. | RDUS | 6 | 6 | 0 | 0.0 |
Cel-Sci Corp. | CVM | 3 | 2 | 1 | 33.3 |
Ironwood Pharmaceuticals Inc - Class A | IRWD | 3 | 2 | 1 | 33.3 |
Surface Oncology Inc | SURF | 6 | 3 | 3 | 50.0 |
Vertex Pharmaceuticals, Inc. | VRTX | 2 | 2 | 0 | 0.0 |
Zai Lab Limited - ADR | ZLAB | 18 | 14 | 4 | 22.2 |
Sorrento Therapeutics Inc | SRNE | 15 | 13 | 2 | 13.3 |
Horizon Therapeutics Plc | HZNP | 12 | 6 | 6 | 50.0 |
Nkarta Inc | NKTX | 0 | 0 | 0 | 0.0 |
IVERIC bio Inc | ISEE | 8 | 6 | 2 | 25.0 |
Scholar Rock Holding Corp | SRRK | 3 | 2 | 1 | 33.3 |
Gossamer Bio Inc | GOSS | 0 | 0 | 0 | 0.0 |
BridgeBio Pharma Inc | BBIO | 4 | 3 | 1 | 25.0 |
Biogen Inc | BIIB | 11 | 10 | 1 | 9.1 |
Kadmon Holdings Inc | KDMN | 3 | 3 | 0 | 0.0 |
Arrowhead Pharmaceuticals Inc. | ARWR | 7 | 5 | 2 | 28.6 |
Spectrum Pharmaceuticals, Inc. | SPPI | 7 | 6 | 1 | 14.3 |
Agios Pharmaceuticals Inc | AGIO | 6 | 5 | 1 | 16.7 |
Alnylam Pharmaceuticals Inc | ALNY | 10 | 9 | 1 | 10.0 |
Precigen Inc | PGEN | 4 | 4 | 0 | 0.0 |
Ocular Therapeutix Inc | OCUL | 6 | 4 | 2 | 33.3 |
Homology Medicines Inc | FIXX | 4 | 3 | 1 | 25.0 |
ITeos Therapeutics Inc | ITOS | 0 | 0 | 0 | 0.0 |
SpringWorks Therapeutics Inc | SWTX | 1 | 1 | 0 | 0.0 |
Medpace Holdings Inc | MEDP | 12 | 9 | 3 | 25.0 |
Vanda Pharmaceuticals Inc | VNDA | 4 | 3 | 1 | 25.0 |
Black Diamond Therapeutics Inc | BDTX | 3 | 2 | 1 | 33.3 |
United Therapeutics Corp | UTHR | 6 | 4 | 2 | 33.3 |